Verenium
Cambridge
About Verenium
Verenium is a biotechnology research firm that offers comprehensive, end-to-end solutions in pre-treatment, innovative enzyme development, fermentation, engineering, and project development. The company is swiftly advancing towards the commercialization of its proprietary technology aimed at producing cellulosic ethanol from various feedstocks, such as sugarcane bagasse, dedicated energy crops, agricultural waste, and wood products. Beyond the significant potential for advanced biofuels, there are numerous large-scale industrial opportunities available for the company related to products generated from affordable, biomass-derived sugars.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $112.5M
- Funding stage: M&A
- Last round: Debt Financing (Dec 2012)
- Website: verenium.com
- Phone: +1 800-523-2990
Industries & Categories
Biotechnology, Industrial, Innovation Management, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/verenium-2741807 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.